I
Ibrahima Ndiaye
Researcher at Cheikh Anta Diop University
Publications - 47
Citations - 1286
Ibrahima Ndiaye is an academic researcher from Cheikh Anta Diop University. The author has contributed to research in topics: Population & Plasmodium falciparum. The author has an hindex of 15, co-authored 39 publications receiving 1135 citations.
Papers
More filters
Journal ArticleDOI
Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
Jean-François Etard,Ibrahima Ndiaye,Marion Thierry-Mieg,Ndeye Fatou Ngom Gueye,Pape Mandoumbé Gueye,Isabelle Lanièce,Allé Baba Dieng,A. Diouf,Christian Laurent,Souleymane Mboup,Papa Salif Sow,Eric Delaporte +11 more
TL;DR: This study underlines the early mortality pattern after HAART initiation and highlights the leading role of mycobacterial infections in the causes of death.
Journal ArticleDOI
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.
B Ndiaye,Friedrich Thienemann,Martin O. C. Ota,Bernard Landry,Makhtar Camara,Siry Dièye,Tandakha Ndiaye Dieye,Hanif Esmail,Hanif Esmail,Rene Goliath,Kris Huygen,Vanessa January,Ibrahima Ndiaye,Tolu Oni,Michael Raine,Marta C. Romano,Iman Satti,Sharon Sutton,Aminata Thiam,Katalin A. Wilkinson,Katalin A. Wilkinson,Souleymane Mboup,Robert J. Wilkinson,Helen McShane +23 more
TL;DR: MVA85A was well tolerated and immunogenic in adults infected with HIV-1, however, the authors detected no efficacy against M tuberculosis infection or disease, although the study was underpowered to detect an effect against disease.
Journal ArticleDOI
Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study)
Halimatou Diop-Ndiaye,Coumba Toure-Kane,Jean-François Etard,Gora Lo,Papa Alassane Diaw,Ndeye Fatou Ngom-Gueye,Pape Mandoumbé Gueye,K. Ba-Fall,Ibrahima Ndiaye,P.S. Sow,Eric Delaporte,Mboup S +11 more
TL;DR: The data indicated that hepatitis pathology in the PLwHIV was essentially due to HBV, and further studies are needed to diagnose occult hepatitis in order to set up therapeutic strategies taking into account co‐infections by hepatitis viruses in the ART programmes.
Journal ArticleDOI
Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria
Jean Louis Ndiaye,Milijaona Randrianarivelojosia,Issaka Sagara,Philippe Brasseur,Ibrahima Ndiaye,Babacar Faye,Laurence Randrianasolo,Arsène Ratsimbasoa,Doris Forlemu,Vicky Jocelyne Ama Moor,Aminata Traore,Yahia Dicko,Niawanlou Dara,Valerie Lameyre,Mouctar Diallo,Abdoulaye Djimde,Albert Same-Ekobo,Oumar Gaye +17 more
TL;DR: The non-inferiority of ASAQ compared with AL was demonstrated and the fixed-dose combination artesunate + amodiaquine (ASAQ) is safe and efficacious even in young children under 5 years of age.
Journal Article
HIV prevention among male clients of female sex workers in Kaolack, Senegal: results of a peer education program.
Lori Leonard,Ibrahima Ndiaye,Asha S. Kapadia,Geoff Eisen,Ousmane Diop,Souleymane Mboup,Phyllis J. Kanki +6 more
TL;DR: The findings indicate that the peer-mediated intervention had a positive impact on several important outcomes measured and suggest that HIV prevention efforts need to focus on male client groups despite the logistical and methodological challenges.